Antiviral potentials of medicinal plants

por Mukhtar, Muhammad, Arshad, Mohammad, Ahmad, Mahmood, Pomerantz, Roger J., Wigdahl, Brian, Parveen, Zahida
Publicado 2008

Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis

por Acheampong, Edward A, Roschel, Cassandra, Mukhtar, Muhammad, Srinivasan, Alagarsamy, Rafi, Mohammad, Pomerantz, Roger J, Parveen, Zahida
Publicado 2009

Rabies virus glycoprotein as a carrier for anthrax protective antigen

por Smith, Mary Ellen, Koser, Martin, Xiao, Sa, Siler, Catherine, McGettigan, James P., Calkins, Catherine, Pomerantz, Roger J., Dietzschold, Bernhard, Schnell, Matthias J.
Publicado 2006

A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis

por Henn, Matthew R., O’Brien, Edward J., Diao, Liyang, Feagan, Brian G., Sandborn, William J., Huttenhower, Curtis, Wortman, Jennifer R., McGovern, Barbara H., Wang-Weigand, Sherry, Lichter, David I., Chafee, Meghan, Ford, Christopher B., Bernardo, Patricia, Zhao, Peng, Simmons, Sheri, Tomlinson, Amelia D., Cook, David N., Pomerantz, Roger J., Misra, Bharat K., Auninš, John G., Trucksis, Michele
Publicado 2021

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial

por McGovern, Barbara H, Ford, Christopher B, Henn, Matthew R, Pardi, Darrell S, Khanna, Sahil, Hohmann, Elizabeth L, O’Brien, Edward J, Desjardins, Christopher A, Bernardo, Patricia, Wortman, Jennifer R, Lombardo, Mary-Jane, Litcofsky, Kevin D, Winkler, Jonathan A, McChalicher, Christopher W J, Li, Sunny S, Tomlinson, Amelia D, Nandakumar, Madhumitha, Cook, David N, Pomerantz, Roger J, Auninš, John G, Trucksis, Michele
Publicado 2020